Mar 29, 2013

Tumor-immune dynamics regulated in the microenvironment inform the transient nature of immune-induced tumor dormancy

Cancer Research
Kathleen P Wilkie, Philip Hahnfeldt


Cancer in a host induces responses that increase the ability of the microenvironment to sustain the growing mass, for example, angiogenesis, but cancer cells can have varying sensitivities to these sustainability signals. Here, we show that these sensitivities are significant determinants of ultimate tumor fate, especially in response to treatments and immune interactions. We present a mathematical model of cancer-immune interactions that modifies generalized logistic growth with both immune-predation and immune-recruitment. The role of a growing environmental carrying capacity is discussed as a possible regulatory mechanism for tumor growth, and this regulation is shown to modify cancer-immune interactions and the possibility of achieving immune-induced tumor dormancy. This mathematical model qualitatively matches experimental observations of immune-induced tumor dormancy as it predicts dormancy as a transient period of growth that necessarily ends in either tumor elimination or tumor escape. As dormant tumors may exist asymptomatically and may be easier to treat with conventional therapy, an understanding of the mechanisms behind tumor dormancy may lead to new treatments aimed at prolonging the dormant state or converting an ...Continue Reading

  • References
  • Citations17


  • We're still populating references for this paper, please check back later.

Mentioned in this Paper

Cancer Microenvironment
Angiogenic Process
Tumor Escape
Tumor Angiogenesis
Cell Communication
Mice, Inbred C3H
Tumor Cells, Malignant
Tumor Volume

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

© 2020 Meta ULC. All rights reserved